English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: This paper reports on a survey performed amongst members of the European Rhinologic Society (ERS) in relation to COVID-19. The survey audited several items, such as (onset of) symptoms that could be a sign of COVID-19, number of patients seen with face-to-face consultation in an outpatient setting, surgeries done, whether personal protective equipment was used, and some personal data including country of practice. Results: Of the 507 respondents, 304 reported one or more complaints (60%); the most common were sore throat, headache, fatigue, stuffy nose and a dry cough. The pattern of complaints of cases tested for COVID-19 was used to create a symptom-based diagnostic construct for COVID-19. Two possibilities were used: (1) anosmia as the only complaint, or combined with either fever and/or shortness of breath (2) a combination of fever, headache, fatigue, dry cough, and coughing up sputum / thick phlegm from the lungs. With these two constructs most patients were adequately classified. A limited percentage of the respondents used/could use adequate personal protection equipment (PPE). In the respondents who were tested for COVID, none with a positive test reported adequate protection 75-100% of the time and 69% no adequate protection at all. Of those with a negative test only 26% reported no protection. Conclusion: This study underlines the importance of adequate protection for ENT surgeons, and especially rhinologists. Furthermore, anosmia is again confirmed as an important marker of COVID-19.